Life Insurers' Q2 Gains Came From Interest Rates, Not Premium Growth

The earnings reports from the big U.S. life insurers this summer carried a tidy headline: premiums are growing, and the extra sales are fueling the profit jump. MetLife's premiums and fees rose 7%, Globe Life's total premiums rose 7%, and the industry's individual life sales ticked up 3%. On the surface, that is a sector selling more insurance and reaping the rewards.

But the numbers underneath don't quite support that story. The premium growth was real but modest — single digits across the board. What actually powered the outsized profit gains, especially in the adjusted figures the companies are most proud of, was something quieter and far less in the insurers' control: the interest rates on the bonds they hold. For a life insurer, that is the difference between a business that is growing and a business that is being carried by a macro tailwind — and that difference is the whole ballgame for how you value these stocks.

The spread that does the real work

The clearest way to see it is through the number that doesn't look like "insurance" at all. MetLife's top line — premiums, fees, and other revenues — grew 7% in the second quarter to $13.7 billion. Fine. But its net investment income, the money it earns on the assets backing its policies, jumped 18% to $6.7 billion. That is a much bigger dollar swing than the revenue growth, and it is the engine behind the result: MetLife's adjusted earnings climbed 15% to $1.6 billion and adjusted earnings per share rose 20% to $2.43.

The mechanism is simpler than it sounds. A life insurer collects premiums now and promises to pay claims and benefits years or decades later. In the meantime it invests the money in bonds and other assets. Its profit is the gap between what those assets earn and what it must guarantee on the policies — the "spread." When interest rates are higher, the new bonds an insurer buys pay more, the spread widens, and earnings go up with very little extra work. High rates did the lifting that the headline attributes to sales.

It is worth being precise about which number is "big," because it matters. MetLife's GAAP net income barely moved — up just 1% to $705 million, or $1.09 a share — because that line also absorbs realized investment losses and periodic assumption updates. The 20% growth lives in the adjusted figure, which strips those out. Both are real, and the "Q2 gains" most people saw were the adjusted number. That is the number the interest-rate spread is quietly inflating.

Premium growth is not the story, and it isn't uniform

The pattern holds across the sector, and it also shows why the "premium growth" framing is too clean. Prudential attributed its group-insurance profit gain specifically to "more favorable mortality... and higher net investment spread" — the company is telling you where the money came from. Its individual life sales hit a record $237 million, up 9%, and its adjusted operating EPS rose to $4.08 from $3.58. But its overall U.S. business income was essentially flat, and that individual life "record" is still a small part of a much larger machine.

Globe Life's life premiums rose only 3%; the 10% jump in its per-share earnings came largely from its health business, with Medicare supplement premiums up 16%, and from underwriting — not from a life-insurance boom. And at Principal Financial, the cleanest counterexample, life insurance premiums and fees actually fell 6%; its earnings held up on favorable markets feeding its retirement business, not on selling more life insurance. Zoom out and the industry-wide figure is the clearest tell of all: new U.S. individual life premium rose just 3% to $4.7 billion in the quarter. That is not a sales boom.

What it means for the price

That is why the durable question is not "are premiums growing fast" but "how long do high rates keep the spread open." The earnings you are seeing this summer are real, but a large slice of them is a byproduct of the current rate environment rather than a structural sales engine the companies can control.

That cuts both ways on the stock, and it is exactly where the interest-rate sensitivity shows up in the price. Prudential, the highest-beta to the spread of the group, trades around 11 times trailing earnings with a dividend yield near 4.5% — more than 5% on its own measure of adjusted book value — after its shares were knocked around by worry that the rate tailwind would fade. If rates stay where they are, that multiple is priced for a weaker spread than the Q2 print is currently delivering, and there is room to close. The Swiss Re Institute has called this a structural "interest rate reset," projecting a 40% rise in insurer investment income over the five years to 2027 — a forecast, not a fact, but one that leans into the durability of the tailwind.

If the Federal Reserve cuts aggressively and the spread narrows, the picture flips. The profit that looked like a boom re-rates down, and the cheap multiple stops looking like a bargain and starts looking like it earned its discount. The Q2 results tell you the engine is running right now. They do not tell you how long the fuel lasts.

For a retirement or income portfolio, that distinction is the whole decision. The premium-growth headline would have you buy on the sales story. The numbers say the returns are coming through the rate-driven spread — so the position is really a bet on how long "higher for longer" holds, wrapped in a stock cheap enough that a moderate version of that bet has some room to work.